GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer
2741.1000 -14.30 (-0.52%)
NSE Sep 19, 2025 15:53 PM
Volume: 85,057
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
02 Aug 2025
2741.10
-0.52%
buy
by Motilal Oswal
Target: 3000 | Upside : 9.4%
Motilal Oswal
GlaxoSmithKline Pharmaceuticals (GLXO) delivered lower-than-expected revenue/EBITDA (8%/5% miss) in 1QFY26.
 
Number of FII/FPI investors increased from 340 to 390 in Jun 2025 qtr.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch | 19 Sep 2025, 03:58PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline | 18 Sep 2025, 03:38PM
From gems to gadgets: India’s $24 billion leap into global smartphone manufacturing
The Baseline | 17 Sep 2025, 06:26PM